Acinetobacter baumannii is recognized as a clinically significant pathogen causing a wide
spectrum of nosocomial infections. Colistin was considered a last-resort antibiotic for the …

Background: Colistin is one of the few remaining options for carbapenem-resistant
Acinetobacter baumannii (A. baumannii); however, emergence of resistance from …

Carbapenem-resistant Acinetobacter baumannii (CR Ab) is a major cause of health care-
associated infections. CR Ab is typically multidrug resistant, and infection is difficult to treat …

Background Infections caused by drug-resistant strains of Acinetobacter baumannii and
Pseudomonas aeruginosa are now a global problem that requires the immediate …

Rapid infection diagnosis is critical to improving patient treatment and outcome. Recent
studies have shown microbial lipids to be sensitive and selective biomarkers for identifying …

This study aimed to investigate the prevalence and resistance mechanisms of colistin-
resistant Acinetobacter baumannii (ColRAB) isolates in Serbia, assess their genetic …

Aims Antimicrobial resistance is a global threat to human health, and Acinetobacter
baumannii is a paradigmatic example of how rapidly bacteria become resistant to clinically …

Even though colistin-based treatment represents the antimicrobial-regimen backbone for the
management of multidrug-resistant Gram-negative infections, colistin resistance is still rare …

The potential of A. baumannii for acquired resistance to last resort antibiotics (colistin and
tigecycline) during treatment has important clinical implications, especially when dealing …

Objectives The emergence of carbapenem-resistant Klebsiella pneumoniae (CRKP) is a
major clinical concern, and polymyxin B (PMB) is a 'last resort'antibiotic for its treatment …